Skip to main content

Advertisement

Table 1 Results from univariate and multivariate survival analyses for a distant metastases-free survival of breast cancer patients

From: The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer

CRIP1
  negative (0) 36 21 / 58%  
  positive (1+, 2+, 3+) 75 28 / 37% p = 0.039
CRIP1 in lymph node-negative tumors
  CRIP1 negative (0) 23 11 / 48%  
  CRIP1 positive (1+, 2+, 3+) 44 11 / 25% p = 0.1 n.s.
CRIP1 in lymph node-positive tumors
  CRIP1 negative (0) 13 10 / 77%  
  CRIP1 positive (1+, 2+, 3+) 33 17 / 52% p = 0.09 n.s.
CRIP1 in HER2-negative tumors (0)
  CRIP1 negative (0) 14 7 / 50%  
  CRIP1 positive (1+, 2+, 3+) 14 5 / 36% p = 0.6 n.s.
CRIP1 in HER2-positive tumors (1+, 2+, 3+)
  CRIP1 negative (0) 21 14 / 67%  
  CRIP1 positive (1+, 2+, 3+) 59 23 / 39% p = 0.021
Multivariate Cox regression analysis
  coefficient chi2 p-value  
nodal status 0.86 7.45 0.006  
tumor size 0.51 4.58 0.03  
CRIP1 −0.66 4.28 0.039 * total p = 0.029
  1. *inverse correlation, Significant p-values are in bold.